Search research articles
Contact Us
Filters
Showing results (201-210 of 373) with videos related to
Page
of 38
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 11, 2025
Cumulative life course impairment: Evidence for hidradenitis suppurativa
Maneli Doroudian Tehrani, Ruby S Gibson, Corey L Snyder, et al.
The American Surgeon
|
December 1, 1978
Heparin utilization during arterial revascularization
G J Collins, D B Kimball, N M Rich, et al.
Nature Reviews. Disease Primers
|
March 14, 2020
Hidradenitis suppurativa
Robert Sabat, Gregor B E Jemec, Łukasz Matusiak, et al.
International Journal of Women'S Dermatology
|
June 10, 2024
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
Corey L Snyder, Ruby S Gibson, Stella X Chen, et al.
JAMA Dermatology
|
May 8, 2024
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab
Simon J Gunter, Zachary E Holcomb, Barbara D Lam, et al.
Biochemistry
|
June 11, 2003
Chain length dependence of apomyoglobin folding: structural evolution from misfolded sheets to native helices
Clement C Chow, Charles Chow, Vinodhkumar Raghunathan, et al.
The British Journal of Dermatology
|
April 23, 2014
Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial
B Zhu, E Edson-Heredia, J Guo, et al.
Dermatology and Therapy
|
October 12, 2018
The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
Alexandra B Kimball, Murali Sundaram, Genevieve Gauthier, et al.
Plastic and Reconstructive Surgery
|
February 28, 2014
Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device
Y Erin Chen, Theodore Gerstle, Kapil Verma, et al.
Circulation
|
March 1, 1994
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial
D Waters, L Higginson, P Gladstone, et al.
Page
of 38
Search research articles
Search
Showing results (201-210 of 373) with videos related to
Sort By:
Page
of 38
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 11, 2025
Cumulative life course impairment: Evidence for hidradenitis suppurativa
Maneli Doroudian Tehrani, Ruby S Gibson, Corey L Snyder, et al.
The American Surgeon
|
December 1, 1978
Heparin utilization during arterial revascularization
G J Collins, D B Kimball, N M Rich, et al.
Nature Reviews. Disease Primers
|
March 14, 2020
Hidradenitis suppurativa
Robert Sabat, Gregor B E Jemec, Łukasz Matusiak, et al.
International Journal of Women'S Dermatology
|
June 10, 2024
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
Corey L Snyder, Ruby S Gibson, Stella X Chen, et al.
JAMA Dermatology
|
May 8, 2024
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab
Simon J Gunter, Zachary E Holcomb, Barbara D Lam, et al.
Biochemistry
|
June 11, 2003
Chain length dependence of apomyoglobin folding: structural evolution from misfolded sheets to native helices
Clement C Chow, Charles Chow, Vinodhkumar Raghunathan, et al.
The British Journal of Dermatology
|
April 23, 2014
Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial
B Zhu, E Edson-Heredia, J Guo, et al.
Dermatology and Therapy
|
October 12, 2018
The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
Alexandra B Kimball, Murali Sundaram, Genevieve Gauthier, et al.
Plastic and Reconstructive Surgery
|
February 28, 2014
Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device
Y Erin Chen, Theodore Gerstle, Kapil Verma, et al.
Circulation
|
March 1, 1994
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial
D Waters, L Higginson, P Gladstone, et al.
Page
of 38